Versant Venture Management, LLC
13F Portfolio Filings
- Most recent 13FQ4 2024
- Locationsan francisco, CA
- CIK0001560009
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
7 | $86.75M | GLUE, CRISPR THERAPEUTICS AG, CTNM, SKYE | 13F-HR | Feb 11, 2025 | 000095012325001612 | ||
6 | $63.57M | CRISPR THERAPEUTICS AG, CTNM, RPTX, SKYE | 13F-HR | Nov 8, 2024 | 000095012324010733 | ||
8 | $77.30M | CRISPR THERAPEUTICS AG, CTNM, SKYE, RPTX | 13F-HR | Aug 7, 2024 | 000095012324007328 | ||
7 | $103.14M | CRISPR THERAPEUTICS AG, SKYE, RPTX, GRTS | 13F-HR | May 3, 2024 | 000095012324003797 | ||
7 | $388.84M | RYZB, CRISPR THERAPEUTICS AG, RPTX, GRTS | 13F-HR | Feb 8, 2024 | 000095012324001156 | ||
8 | $188.11M | RYZB, RPTX, CRISPR THERAPEUTICS AG, ADVM | 13F-HR | Nov 3, 2023 | 000095012323009395 | ||
8 | $84.30M | RPTX, CRISPR THERAPEUTICS AG, ADVM, GRTS | 13F-HR | Aug 9, 2023 | 000095012323007098 | ||
7 | $47.97M | CRISPR THERAPEUTICS AG, GRTS, PASG, CBAY | 13F-HR | May 11, 2023 | 000095012323004367 | ||
7 | $48.33M | CRISPR THERAPEUTICS AG, GRTS, PASG, CBAY | 13F-HR | Feb 9, 2023 | 000095012323001275 | ||
8 | $58.66M | CRISPR THERAPEUTICS AG, GRTS, PASG, ADVM | 13F-HR | Nov 10, 2022 | 000095012322011472 | ||
8 | $65.23M | CRISPR THERAPEUTICS AG, PASG, GRTS, ADVM | 13F-HR | Aug 11, 2022 | 000095012322008452 | ||
10 | $100.17M | CRISPR THERAPEUTICS AG, PASG, GRTS, CRNX | 13F-HR | May 10, 2022 | 000095012322005030 | ||
10 | $186.97M | GRTS, CRISPR THERAPEUTICS AG, PASG, ALGS | 13F-HR | Feb 11, 2022 | 000095012322001851 | ||
11 | $241.51M | CRISPR THERAPEUTICS AG, PASG, GRTS, ALGS | 13F-HR | Nov 12, 2021 | 000095012321014984 | ||
11 | $301.81M | CRISPR THERAPEUTICS AG, PASG, ALGS, GRTS | 13F-HR | Aug 12, 2021 | 000095012321010561 | ||
11 | $513.26M | CRISPR THERAPEUTICS AG, PASG, ALGS, ADVM | 13F-HR | May 7, 2021 | 000095012321005457 | ||
12 | $962.97M | CRISPR THERAPEUTICS AG, NARI, ALGS, ADVM | 13F-HR | Feb 16, 2021 | 000095012321002373 | ||
11 | $546.37M | CRISPR THERAPEUTICS AG, ADVM, APREA THERAPEUTICS INC, FLXN | 13F-HR | Nov 12, 2020 | 000095012320011532 | ||
12 | $696.07B | CRISPR THERAPEUTICS AG, ADVM, APREA THERAPEUTICS INC, AKRO | 13F-HR | Jul 20, 2020 | 000110465920084768 | ||
9 | $364.64B | CRISPR THERAPEUTICS AG, ADVM, AKRO, VCYT | 13F-HR | Apr 28, 2020 | 000110465920052226 | ||
7 | $331.85B | CRISPR THERAPEUTICS AG, VCYT, GRTS, OCUL | 13F-HR | Jan 21, 2020 | 000110465920005491 | ||
8 | $258.45B | CRISPR THERAPEUTICS AG, VCYT, GRTS, 2393707D | 13F-HR | Oct 8, 2019 | 000110465919053357 | ||
9 | $343.19B | CRISPR THERAPEUTICS AG, VCYT, GRTS, 2393707D | 13F-HR | Jul 12, 2019 | 000110465919039996 | ||
9 | $303.57B | CRISPR THERAPEUTICS AG, VCYT, 2393707D, CBAY | 13F-HR | Apr 5, 2019 | 000110465919020144 | ||
10 | $202.02B | CRISPR THERAPEUTICS AG, VCYT, 2393707D, OCUL | 13F-HR | Jan 22, 2019 | 000110465919002754 | ||
10 | $294.01B | CRISPR THERAPEUTICS AG, 2393707D, VCYT, OCUL | 13F-HR | Oct 5, 2018 | 000110465918060749 | ||
9 | $320.53B | CRISPR THERAPEUTICS AG, 2393707D, OCUL, CBAY | 13F-HR | Jul 13, 2018 | 000110465918045045 | ||
8 | $312.68B | CRISPR THERAPEUTICS AG, 2393707D, AKAOQ, OCUL | 13F-HR | May 3, 2018 | 000110465918030300 | ||
7 | $95.03B | 2393707D, AKAOQ, OCUL, CBAY | 13F-HR | Jan 25, 2018 | 000110465918003973 | ||
8 | $131.38B | 2393707D, IMDZ, AKAOQ, OCUL | 13F-HR | Oct 13, 2017 | 000110465917062084 | ||
8 | $127.13B | 2393707D, AKAOQ, IMDZ, OCUL | 13F-HR | Aug 2, 2017 | 000110465917048730 | ||
8 | $137.51B | AKAOQ, 2393707D, CLVSQ, OCUL | 13F-HR | Apr 7, 2017 | 000110465917022191 | ||
7 | $102.74B | 2393707D, OCUL, CLVSQ, AKAOQ | 13F-HR | Jan 18, 2017 | 000110465917002761 | ||
7 | $89.69B | 2393707D, IMDZ, OCUL, CLVSQ | 13F-HR | Oct 24, 2016 | 000110465916151423 | ||
5 | $98.67B | GKOS, OCUL, CLVSQ, AKAOQ | 13F-HR | Jul 28, 2016 | 000110465916135018 | ||
7 | $138.52B | GKOS, FPRX, OCUL, CLVSQ | 13F-HR | Apr 25, 2016 | 000110465916113751 | ||
7 | $170.90B | GKOS, FPRX, OCUL, CLVSQ | RESTATEMENT | May 5, 2016 | 000110465916118185 | ||
7 | $174.36B | GKOS, CLVSQ, OCUL, FPRX | 13F-HR | Oct 28, 2015 | 000110465915073439 | ||
5 | $78.84B | CLVSQ, FPRX, AKAOQ, BITI | 13F-HR | Jul 15, 2015 | 000110465915051249 | ||
6 | $113.70B | CLVSQ, FPRX, AKAOQ, CBAY | 13F-HR | Apr 23, 2015 | 000110465915029755 | ||
5 | $104.59B | CLVSQ, FPRX, AKAOQ, CBAY | RESTATEMENT | Apr 23, 2015 | 000110465915029709 | ||
6 | $113.70B | CLVSQ, FPRX, AKAOQ, CBAY | RESTATEMENT | Apr 22, 2015 | 000110465915029151 |